SG
HOLX

Societe Generale’s Hologic HOLX Stock Holding History

Societe Generale’s Portfolio HOLX Stock Details HOLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$2.4M Buy
+69,480
New +$2.41M 0.02% 746

Other funds holding HOLX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
Tran Capital Management San Rafael, California $869M AUM 52.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Societe Generale's HOLX Position: Q2 2016 in Review

Societe Generale opened a new position in Hologic (HOLX) in Q2 2016: 69,480 shares worth $2.4M. The stake represents 0.02% of the portfolio and ranks #746 among its holdings.

459 funds tracked by Wall St. Rank hold HOLX as of Q2 2016.

  • Societe Generale held 69,480 shares of Hologic worth $2.4M as of Q2 2016.
  • Hologic was a new Societe Generale position in Q2 2016.
  • Hologic made up 0.02% of Societe Generale's portfolio in Q2 2016, its #746 holding.
  • 459 funds tracked by Wall St. Rank held Hologic as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.